Response to Commentary on ‘“Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort”

• Louisa Bolm, MD,
• Martina Nebbia, MD,
• Alice C. Wei, MD,
• Amer H. Zureikat, MD,
• Carlos Fernández-del Castillo, MD,
• Jian Zheng, MD,
• Alessandra Pulvirenti, MD,
• Ammar A. Javed, MD,
• Yurie Sekigami, MD,
• Natalie Petruch,
• Motaz Qadan, MD, PhD,
• Keith D. Lillemoe, MD,
• Jin He, MD,
• Cristina R. Ferrone, MD,
• the Pancreatic Neuroendocrine Disease Alliance (PANDA)

Affiliations

Louisa Bolm, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Martina Nebbia, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Alice C. Wei, MD

† Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

Amer H. Zureikat, MD

‡ Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA

Carlos Fernández-del Castillo, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Jian Zheng, MD

‡ Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA

Alessandra Pulvirenti, MD

† Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

Ammar A. Javed, MD

§ Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.

Yurie Sekigami, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Natalie Petruch

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Motaz Qadan, MD, PhD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Keith D. Lillemoe, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Jin He, MD

§ Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.

Cristina R. Ferrone, MD

From the * Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

the Pancreatic Neuroendocrine Disease Alliance (PANDA)